21 matches for your search in the start-up spotlight
rss
We are a spin-off company out of the Angiology Division of the Lausanne University Hospital (CHUV) and of the Laboratory of Lymphatic and Cancer Bioengineering of the Swiss Federal Institute of Technology in Lausanne (EPFL). Lymphatica Medtech was founded in 2017 by Dr. Triacca and Dr. Pisano, ...
Isospec Analytics is an EPFL spin-off based in Lausanne – Switzerland, whose mission is to implement technology to discover new disease biomarkers, accelerate the development of therapeutics and transform the future of clinical nutrition.
Vandria is at the vanguard of mitochondrial therapeutics. It is developing first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318 is a brain-penetrant, patent-protected, mitophagy inducer which has been shown to acutely improve ...
Embion is a chemical process technology EPFL spin-off, commercializing a novel catalytic process that allows the use of sustainable resources in the form of 2nd generation lignocellulosic biomass for producing food ingredients, chemicals and fuels. Our process helps reducing the carbon footprint ...
Embion is a chemical process technology EPFL spin-off, commercializing a novel catalytic process that allows the use of sustainable resources in the form of 2nd generation lignocellulosic biomass for producing food ingredients, chemicals and fuels. Our process helps reducing the carbon footprint ...
The Alpine Institute for Drug Discovery (AIDD) is an enterprise aiming at creating shared value for the community and working with academic researchers, technology transfer offices and local incubators to commercialise academic discoveries with therapeutic potential. Working in collaboration with ...
GenomSys is a Swiss company composed by engineers with extensive experience in research, development and project management in high-end domains and industrial segments such as digital signal processing, telecommunications, information security and avionics. Their experience spans from embedded ...
Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases ...
